Serum Calprotectin in Rheumatoid Arthritis: A Promising Diagnostic Marker, How Far Is It Related to Activity and Sonographic Findings?
Background: In the past 2 decades, there has been increasing interest in calprotectin. It is released and detected in serum and body fluids as a potentially useful clinical inflammatory marker. The protein has been described in synovial tissue in rheumatoid arthritis (RA) patients, specifically in t...
Main Authors: | H.E. Mansour, M.A. Abdullrhman, S.A. Mobasher, Reem El Mallah, Nouran Abaza, F. Hamed, Adham Aboul Fotouh Khalil |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-03-01
|
Series: | Journal of Medical Ultrasound |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929644116300911 |
Similar Items
-
Potential role of calprotectin as a monitoring biomarker for clinical and sonographic activity and treatment outcome in recent-onset rheumatoid arthritis
by: Amal F Soliman, et al.
Published: (2016-01-01) -
Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis
by: Matthias Jarlborg, et al.
Published: (2020-05-01) -
Serum Calprotectin is Indicating Clinical and Ultrasonographic Disease Activity in Rheumatoid Arthritis, even with Normal C-Reactive Protein Levels
by: Murat Torgutalp, et al.
Published: (2021-01-01) -
CLINICAL SIGNIFICANCE OF CALPROTECTIN IN RHEUMATIC DISEASES
by: A. S. Avdeeva
Published: (2018-09-01) -
CHANGES IN CALPROTECTIN LEVEL, ITS RELATIONSHIP TO THE CLINICAL AND LABORATORY PARAMETERS OF DISEASE ACTIVITY AND SIGNIFICANCE FOR PREDICTING THE THERAPEUTIC RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ETANERCEPT
by: A. O. Pchelintseva, et al.
Published: (2015-09-01)